Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q2 2025 Earnings Call Transcript
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q2 2025 Earnings Call Transcript August 13, 2025Mersana Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ EPS, expectations were $-3.75.



